JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.62% |
| 2 | Healthcare | 12.48% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
PAR Technology
PAR
$788M
| $866K | ﹤0.01% |
29,319
+316
| +1% | +$11.7K |
|
|
ATRI
3902
DELISTED
Atrion Corp
ATRI
| $866K | ﹤0.01% |
1,533
+68
| +5% | +$42.3K |
|
3903
HealthStream
HSTM
$846M
| $864K | ﹤0.01% |
40,662
-60
| -0.1% | -$1.36K |
|
3904
CALL
Insmed
INSM
$27B
| $864K | ﹤0.01% |
+40,100
| New | +$961K |
|
3905
Sutro Biopharma
STRO
$340M
| $864K | ﹤0.01% |
15,558
-85
| -0.5% | -$5.03K |
|
3906
CALL
Veru
VERU
$46.5M
| $864K | ﹤0.01% |
+7,500
| New | +$1.08M |
|
|
AGGR
3907
DELISTED
Agile Growth Corp
AGGR
| $863K | ﹤0.01% |
86,925
-465,408
| -84% | -$4.58M |
|
|
EIGR
3908
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $862K | ﹤0.01% |
3,814
-8
| -0.2% | -$1.97K |
|
3909
ATN International
ATNI
$488M
| $861K | ﹤0.01% |
22,307
-604
| -3% | -$27.4K |
|
3910
PUT
Bumble
BMBL
$358M
| $860K | ﹤0.01% |
+40,000
| New | +$1.18M |
|
3911
Castle Biosciences
CSTL
$905M
| $860K | ﹤0.01% |
32,949
+2,826
| +9% | +$79.2K |
|
|
SA
3912
Seabridge Gold
SA
$3.62B
| $860K | ﹤0.01% |
72,515
-25,502
| -26% | -$323K |
|
|
KRTX
3913
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $855K | ﹤0.01% |
+3,800
| New | +$769K |
|
|
LGTY
3914
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $854K | ﹤0.01% |
55,714
+1,189
| +2% | +$20.2K |
|
3915
Entravision Communication
EVC
$832M
| $851K | ﹤0.01% |
214,435
-10,645
| -5% | -$52.7K |
|
3916
CALL
Ford
F
$57.3B
| $850K | ﹤0.01% |
75,900
| – | – |
|
|
TPC
3917
Tutor Perini Cor
TPC
$5.09B
| $848K | ﹤0.01% |
153,671
-13,186
| -8% | -$100K |
|
3918
Helix Energy Solutions
HLX
$1.54B
| $845K | ﹤0.01% |
218,702
+19,876
| +10% | +$75.4K |
|
3919
Revolve Group
RVLV
$1.68B
| $845K | ﹤0.01% |
38,967
+275
| +0.7% | +$7.23K |
|
|
ALLG
3920
DELISTED
Allego N.V.
ALLG
| $845K | ﹤0.01% |
+193,771
| New | +$860K |
|
3921
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.41B
| $844K | ﹤0.01% |
22,388
| – | – |
|
3922
Brookfield Infrastructure Partners
BIP
$18.3B
| $843K | ﹤0.01% |
23,481
-1,950
| -8% | -$78.3K |
|
|
THR
3923
DELISTED
Thermon Group Holdings
THR
| $843K | ﹤0.01% |
54,677
-275
| -0.5% | -$4.52K |
|
|
PSTL
3924
Postal Realty Trust
PSTL
$696M
| $840K | ﹤0.01% |
57,243
-13,930
| -20% | -$217K |
|
3925
Inogen
INGN
$153M
| $839K | ﹤0.01% |
34,533
+845
| +3% | +$23.3K |
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 557 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 557 new positions and closed 516 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.